Clinical Trial Update: BCG for Therapeutic Use Phase I Clinical Trial [Phase 1]

View source ↗

Summary

This Phase I study evaluated therapeutic Bacillus Calmette-Guérin for non-muscle invasive bladder cancer and has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-muscle Invasive Bladder Cancer

Drugs mentioned

• BCG (Bacillus Calmette-Guérin)

Snippet

Sponsor: Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd. | Conditions: Non-muscular Invasive Bladder Cancer | Phase 1 | Status: COMPLETED